BIOPHARMACEUTICAL AND CLINICAL PHARMACOKINETIC PROFILE OF BROMAZEPAM

[1] BIEL JH, 1967, ANN REPORTS MED CHEM, P11

[2] BOXER GE, 1948, J PHARMACOL EXP THER, V92, P226

[3] DETERMINATION OF BROMAZEPAM IN BLOOD BY ELECTRON-CAPTURE GLC AND ITS MAJOR URINARY METABOLITES BY DIFFERENTIAL PULSE POLAROGRAPHY [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (09) : 1440 - 1445

[4] USE OF CANNULATED EVERTED INTESTINAL SAC FOR SERIAL SAMPLING AS A DRUG ABSORBABILITY (PERMEABILITY) SCREEN [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (09) : 1361 - &

[5] Kaplan SA, 1974, DISSOLUTION TECHNOLO, P167

[6] KERRY RJ, 1972, PSYCHOSOMATICS, V13, P122

[7] RAAFLAUB J, 1974, ARZNEIMITTEL-FORSCH, V24, P1841

[8] RICKELS K, 1973, CURR THER RES CLIN E, V15, P679

[9] URINARY METABOLITE OF BROMAZEPAM [J]. EXPERIENTIA, 1972, 28 (04): : 393 - +

[10] SAWADA H, 1972, J PHARM SOC JAP, V92, P1237

[1] BIEL JH, 1967, ANN REPORTS MED CHEM, P11

[2] BOXER GE, 1948, J PHARMACOL EXP THER, V92, P226

[3] DETERMINATION OF BROMAZEPAM IN BLOOD BY ELECTRON-CAPTURE GLC AND ITS MAJOR URINARY METABOLITES BY DIFFERENTIAL PULSE POLAROGRAPHY [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (09) : 1440 - 1445

[4] USE OF CANNULATED EVERTED INTESTINAL SAC FOR SERIAL SAMPLING AS A DRUG ABSORBABILITY (PERMEABILITY) SCREEN [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (09) : 1361 - &

[5] Kaplan SA, 1974, DISSOLUTION TECHNOLO, P167

[6] KERRY RJ, 1972, PSYCHOSOMATICS, V13, P122

[7] RAAFLAUB J, 1974, ARZNEIMITTEL-FORSCH, V24, P1841

[8] RICKELS K, 1973, CURR THER RES CLIN E, V15, P679

[9] URINARY METABOLITE OF BROMAZEPAM [J]. EXPERIENTIA, 1972, 28 (04): : 393 - +

[10] SAWADA H, 1972, J PHARM SOC JAP, V92, P1237